For these analyses, we utilized the basal-like MDA-MB-468 breast cancer cell line, which demonstrated robust LDHC knockdown efficiency and the highest increase in T cell-mediated cancer cell cytotoxicity following LDHC silencing. The gene discussed is LDHC; the disease is breast carcinoma.